Credit Suisse Ag Abbott Laboratories Call Options Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $1.81 Million - $2.22 Million	-15,700 Reduced 3.82%	395,100 $55.6 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $5.86 Million - $6.48 Million	-50,200 Reduced 10.89%	410,800 $48.5 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $25.3 Million - $29.8 Million	-239,000 Reduced 34.14%	461,000 $54 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $13.2 Million - $15.6 Million	-121,400 Reduced 14.78%	700,000 $83.9 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $19.8 Million - $21.6 Million	188,600 Added 29.8%	821,400 $89.9 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $33.7 Million - $41 Million	368,000 Added 138.97%	632,800 $68.9 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $12.5 Million - $16 Million	163,700 Added 161.92%	264,800 $24.2 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $6.81 Million - $9.96 Million	-108,400 Reduced 51.74%	101,100 $7.98 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $9.7 Million - $10.8 Million	123,600 Added 143.89%	209,500 $18.2 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $1.64 Million - $1.77 Million	-20,000 Reduced 18.89%	85,900 $7.19 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $6.23 Million - $7.27 Million	-85,500 Reduced 44.67%	105,900 $8.91 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $9.77 Million - $11.8 Million	-147,600 Reduced 43.54%	191,400 $15.3 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $12.4 Million - $14.1 Million	189,700 Added 127.06%	339,000 $24.5 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $2.23 Million - $2.69 Million	-36,700 Reduced 19.73%	149,300 $11 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $6.34 Million - $7 Million	110,200 Added 145.38%	186,000 $11.3 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $6.99 Million - $7.9 Million	-124,200 Reduced 62.1%	75,800 $4.54 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $4 Million - $4.29 Million	-74,600 Reduced 27.17%	200,000 $11.4 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $8.39 Million - $9.37 Million	174,600 Added 174.6%	274,600 $14.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	100,000	100,000 $4.86 Million

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$18.9 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$14.7 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.62 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.38 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$5.99 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account